Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Baylin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Cell|June 28, 2002
Altered methylation patterns in cancer cell genomes: cause or consequence?Stephen Baylin, Timothy H Bestor
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 12, 2007
The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities researchM Chris Gibbons, Malcolm Brock, Anthony J Alberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 6, 2013
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic eventsBrian Keeley, Alejandro Stark, Thomas R Pisanic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Epigenetic Instability Based Metrics in Cell-Free DNA for Early Cancer DetectionSara-Jayne Thursby, Zhicheng Jin, Jacob Blum, et al.
The Journal of Surgical Research|August 30, 2011
A murine xenograft model of spontaneous metastases of human lung adenocarcinomaJames E Harris, James Shin, Beverly Lee, et al.
Oncotarget|February 20, 2016
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Nature Communications|August 6, 2024
DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentationMichaël Noë, Dimitrios Mathios, Akshaya V Annapragada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to IrinotecanValerie Lee, Judy Wang, Marianna Zahurak, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Cell|June 28, 2002
Altered methylation patterns in cancer cell genomes: cause or consequence?Stephen Baylin, Timothy H Bestor
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 12, 2007
The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities researchM Chris Gibbons, Malcolm Brock, Anthony J Alberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 6, 2013
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic eventsBrian Keeley, Alejandro Stark, Thomas R Pisanic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Epigenetic Instability Based Metrics in Cell-Free DNA for Early Cancer DetectionSara-Jayne Thursby, Zhicheng Jin, Jacob Blum, et al.
The Journal of Surgical Research|August 30, 2011
A murine xenograft model of spontaneous metastases of human lung adenocarcinomaJames E Harris, James Shin, Beverly Lee, et al.
Oncotarget|February 20, 2016
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Nature Communications|August 6, 2024
DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentationMichaël Noë, Dimitrios Mathios, Akshaya V Annapragada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to IrinotecanValerie Lee, Judy Wang, Marianna Zahurak, et al.
Pageof 2